Pharma companies disguise themselves as gentle and caring lambs working hard to save lives. The scale of money involved in rare diseases cure is disproportional to resulting benefits. This is a cover up for industrial elites to live a safe and wealthy existence, whereas their technology lags behind and development progress is much slower than in other industries. Increasingly the work is offshored and the pharma companies mostly add to the cost being the wealth-consuming part in the chain. In contrast to rare diseases and gene and cell therapy that may be focused on small numbers of patients, vaccines are directed towards large populations and must be developed quickly. Being from vaccine field we have little respect for people who doodle for years to develop some marginal drugs and getting rich in the process

At last JPM Conference in SF the wonderful management team demonstrated how they will rune the company. To the ground.

Interesting how Amgen is going to adjust to policies of new administration and how this would affect jobs?

Layoffs! Cell therapy in question. Gilead is in retreat, so how about Kite? Cell therapy is like a laboratory and clinical procedure development, not a typical pharma drug development. Often at enormous cost. And a market size and economics?